Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• Ravaud A, Motzer RJ, Pandha HS, et al. Adjuvant sunitinib in high-risk renal-cell carcinoma after nephrectomy. N Engl J Med. 2016;375(23):2246–2254. doi:10.1056/NEJMoa161140627718781
   PubMed Web of Science ®Google Scholar
• Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v58–58v68. doi:10.1093/annonc/mdw32827664262
   PubMed Web of Science ®Google Scholar
• Rini BI, Escudier B, Tomczak P, et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised Phase 3 trial. Lancet. 2011;378(9807):1931–1939. doi:10.1016/S0140-6736(11)61613-922056247
   PubMed Web of Science ®Google Scholar
• Sh Z. Adjuvant Sunitinib in Renal-Cell Carcinoma. N Engl J Med. 2017;376(9):893.
   Web of Science ®Google Scholar
• Motzer RJ, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007;356(2):115–124. doi:10.1056/NEJMoa06504417215529
   PubMed Web of Science ®Google Scholar
• Sternberg CN, Davis ID, Mardiak J, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized Phase III trial. J Clin Oncol. 2010;28(6):1061–1068. doi:10.1200/JCO.2009.23.976420100962
   PubMed Web of Science ®Google Scholar
• Schmidinger M. Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors. EJC Suppl. 2013;11(2):172–191. doi:10.1016/j.ejcsup.2013.07.01626217127
   PubMedGoogle Scholar
• Appleby L, Morrissey S, Bellmunt J, Rosenberg J. Management of treatment-related toxicity with targeted therapies for renal cell carcinoma: evidence-based practice and best practices. Hematol Oncol Clin North Am. 2011;25(4):893–915. doi:10.1016/j.hoc.2011.05.00421763973
   PubMed Web of Science ®Google Scholar
• Dzutsev A, Goldszmid RS, Viaud S, Zitvogel L, Trinchieri G. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. Eur J Immunol. 2015;45(1):17–31. doi:10.1002/eji.20144497225328099
   PubMed Web of Science ®Google Scholar
• De Santis S, Cavalcanti E, Mastronardi M, Jirillo E, Chieppa M. Nutritional keys for intestinal barrier modulation. Front Immunol. 2015;6:612. doi:10.3389/fimmu.2015.0061226697008
   PubMed Web of Science ®Google Scholar
• Vaishnava S, Behrendt CL, Ismail AS, Eckmann L, Hooper LV. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc Natl Acad Sci U S A. 2008;105(52):20858–20863. doi:10.1073/pnas.080872310519075245
   PubMed Web of Science ®Google Scholar
• Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014;14(3):141–153. doi:10.1038/nri360824566914
   PubMed Web of Science ®Google Scholar
• Janelsins BM, Lu M, Datta SK. Altered inactivation of commensal LPS due to acyloxyacyl hydrolase deficiency in colonic dendritic cells impairs mucosal Th17 immunity. Proc Natl Acad Sci U S A. 2014;111(1):373–378. doi:10.1073/pnas.131198711124344308
   PubMed Web of Science ®Google Scholar
• Park JH, Jeong SY, Choi AJ, Kim SJ. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett. 2015;165(1):10–19. doi:10.1016/j.imlet.2015.03.00325794633
   PubMed Web of Science ®Google Scholar
• Roy S, Trinchieri G. Microbiota: a key orchestrator of cancer therapy. Nat Rev Cancer. 2017;17(5):271–285. doi:10.1038/nrc.2017.1328303904
   PubMed Web of Science ®Google Scholar
• Fan L, Iseki S. Immunohistochemical localization of vascular endothelial growth factor in the endocrine glands of the rat. Arch Histol Cytol. 1998;61(1):17–28. doi:10.1679/aohc.61.179557964
   PubMedGoogle Scholar
• Chowdhury N, Drake CG. Kidney cancer: an overview of current therapeutic approaches. Urol Clin North Am. 2020;47(4):419–431. doi:10.1016/j.ucl.2020.07.00933008493
   PubMed Web of Science ®Google Scholar
• Rizzo A, Mollica V, Santoni M, Massari F. Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2021;15(10):1225–1232. doi:10.1080/17474124.2021.194832834167420
   PubMed Web of Science ®Google Scholar
• Pal SK, Li SM, Wu X, et al. Stool bacteriomic profiling in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor-tyrosine kinase inhibitors. Clin Cancer Res. 2015;21(23):5286–5293. doi:10.1158/1078-0432.CCR-15-072426152743
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. doi:10.1038/nmeth.f.30320383131
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998. doi:10.1038/nmeth.260423955772
   PubMed Web of Science ®Google Scholar
• Amato KR, Yeoman CJ, Kent A, et al. Habitat degradation impacts black howler monkey (Alouatta pigra) gastrointestinal microbiomes. ISME J. 2013;7(7):1344–1353. doi:10.1038/ismej.2013.1623486247
   PubMed Web of Science ®Google Scholar
• Wang Y, Sheng HF, He Y, et al. Comparison of the levels of bacterial diversity in freshwater, intertidal wetland, and marine sediments by using millions of illumina tags. Appl Environ Microbiol. 2012;78(23):8264–8271. doi:10.1128/AEM.01821-1223001654
   PubMed Web of Science ®Google Scholar
• Bates ST, Clemente JC, Flores GE, et al. Global biogeography of highly diverse protistan communities in soil. ISME J. 2013;7(3):652–659. doi:10.1038/ismej.2012.14723235291
   PubMed Web of Science ®Google Scholar
• Jiang XT, Peng X, Deng GH, et al. Illumina sequencing of 16S rRNA tag revealed spatial variations of bacterial communities in a mangrove wetland. Microb Ecol. 2013;66(1):96–104. doi:10.1007/s00248-013-0238-823649297
   PubMed Web of Science ®Google Scholar
• Oberauner L, Zachow C, Lackner S, Högenauer C, Smolle KH, Berg G. The ignored diversity: complex bacterial communities in intensive care units revealed by 16S pyrosequencing. Sci Rep. 2013;3:1413. doi:10.1038/srep0141323475210
   PubMed Web of Science ®Google Scholar
• Zhang C, Li S, Yang L, et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun. 2013;4:2163. doi:10.1038/ncomms316323860099
   PubMed Web of Science ®Google Scholar
• Liu J, Nicum S, Reichardt P, et al. Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer. Gynecol Oncol. 2018;150(1):173–179. doi:10.1016/j.ygyno.2018.03.05829627080
   PubMed Web of Science ®Google Scholar
• Armani RG, Ramezani A, Yasir A, Sharama S, Canziani M, Raj DS. Gut microbiome in chronic kidney disease. Curr Hypertens Rep. 2017;19(4):29.28343357
   PubMed Web of Science ®Google Scholar
• Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A. 2012;109(2):594–599. doi:10.1073/pnas.111605310922184244
   PubMed Web of Science ®Google Scholar
• Jie Z, Xia H, Zhong SL, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845. doi:10.1038/s41467-017-00900-129018189
   PubMed Web of Science ®Google Scholar
• Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi:10.1038/nature1145023023125
   PubMed Web of Science ®Google Scholar
• Qin N, Yang F, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014;513(7516):59–64. doi:10.1038/nature1356825079328
   PubMed Web of Science ®Google Scholar
• Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci U S A. 1999;96(17):9833–9838. doi:10.1073/pnas.96.17.983310449780
   PubMed Web of Science ®Google Scholar
• Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett. 2009;294(1):1–8. doi:10.1111/j.1574-6968.2009.01514.x19222573
   PubMed Web of Science ®Google Scholar
• Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 2017;67(4):326–344. doi:10.3322/caac.2139828481406
   PubMed Web of Science ®Google Scholar
• Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–5267. doi:10.1128/AEM.00062-0717586664
   PubMed Web of Science ®Google Scholar
• Tu P, Bian X, Chi L, et al. Characterization of the functional changes in mouse gut microbiome associated with increased akkermansia muciniphila population modulated by dietary black raspberries. ACS Omega. 2018;3(9):10927–10937. doi:10.1021/acsomega.8b0006430288460
   PubMed Web of Science ®Google Scholar
• Massari F, Rizzo A, Mollica V, et al. Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials. Eur J Cancer. 2021;154:120–127. doi:10.1016/j.ejca.2021.06.01534265504
   PubMed Web of Science ®Google Scholar
• Salgia NJ, Bergerot PG, Maia MC, et al. Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti-PD-1 immune checkpoint inhibitors. Eur Urol. 2020;78(4):498–502. doi:10.1016/j.eururo.2020.07.01132828600
   PubMed Web of Science ®Google Scholar
• Mi H, Dong Y, Zhang B, et al. Bifidobacterium infantis ameliorates chemotherapy-induced intestinal mucositis via regulating T cell immunity in colorectal cancer rats. Cell Physiol Biochem. 2017;42(6):2330–2341. doi:10.1159/00048000528848081
   PubMedGoogle Scholar
• Chang CW, Liu CY, Lee HC, et al. Lactobacillus casei variety rhamnosus probiotic preventively attenuates 5-fluorouracil/oxaliplatin-induced intestinal injury in a syngeneic colorectal cancer model. Front Microbiol. 2018;9:983. doi:10.3389/fmicb.2018.0098329867884
   PubMed Web of Science ®Google Scholar
• Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. J Cell Physiol. 2018;233(3):2091–2103. doi:10.1002/jcp.2591128294322
   PubMed Web of Science ®Google Scholar
• Mego M, Chovanec J, Vochyanova-Andrezalova I, et al. Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complement Ther Med. 2015;23(3):356–362. doi:10.1016/j.ctim.2015.03.00826051570
   PubMed Web of Science ®Google Scholar
• Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–450. doi:10.1038/nature1272124226770
   PubMed Web of Science ®Google Scholar